The latest prostate cancer news
High-intensity focused ultrasound (HIFU) can control prostate cancer with fewer side effects
In recent years, a new treatment strategy known as focal therapy (partial gland ablation) has…
Browsing: Prostate Cancer
High-intensity focused ultrasound can control prostate cancer with fewer side effects
In recent years, a new treatment strategy known as focal therapy (partial gland ablation) has emerged for prostate…
Researchers contribute to discovery of mechanism leading to drug resistance in prostate cancer
Prostate cancer is the most common cancer among men in the United States. Many patients…
ASCO 2022: Three-year follow up results from the TheraP study for metastatic prostate cancer
The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) reports the three-year…
ASCO 2022: The updated results from the ENZAMET clinical trial
The Australian-led clinical trial ENZAMET has shown that the addition of hormone therapy with a…
Common prostate cancer medications may be less safe than previously thought
Men taking either of the two most common oral medications for advanced prostate cancer who…
New cancer subtype may illuminate treatment strategy
Researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center, USA, have identified a…
Scientists identify new — and very common — subtype of prostate cancer
A previously unknown subtype of hormone-resistant prostate cancer accounts for about 30% of all cases,…
Electrochemical biosensor detects prostate cancer
Biomarkers are components that may be present in biological samples and are related to specific…
Men with prostate cancer have a higher risk of serious blood clots
New research published in the online journal BMJ Open suggests that men with prostate cancer have a…